Compass Therapeutics | DEFA14A: Others
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 10-Q: Quarterly report
Compass Therapeutics | 8-K: Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
Compass Therapeutics | ARS: Annual Report to Security Holders
Compass Therapeutics | DEFA14A: Others
Compass Therapeutics | DEF 14A: Definitive information statements
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(13.7%),OrbiMed Capital GP V LLC(11.1%), etc.
Compass Therapeutics | 10-K: Annual report
Compass Therapeutics | 8-K: Current report
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boylan James P
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GORDON CARL L
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRAY MARY ANN
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LINDAHL RICHARD S
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ferneau Philip
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chiniara Ellen
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bisker-Leib Vered
Compass Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schuetz Thomas J.
Compass Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(3.570%),Abigail P. Johnson(3.570%)
No Data